BDB563611

CD52 Mouse anti-Human, APC-H7, Clone: 4C8, BD

Manufacturer: BD Biosciences

Select a Size

Pack Size SKU Availability Price
Each of 1 BDB563611-Each-of-1 In Stock ₹ 23,095.50

BDB563611 - Each of 1

₹ 23,095.50

In Stock

Quantity

1

Base Price: ₹ 23,095.50

GST (18%): ₹ 4,157.19

Total Price: ₹ 27,252.69

Antigen

CD52

Classification

Monoclonal

Conjugate

APC-H7

Formulation

Aqueous buffered solution containing BSA, protein stabilizer, and ≤0.09% sodium azide.

Immunogen

Human T lymphocytes

Quantity

50 Tests

Primary or Secondary

Primary

Content And Storage

Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.

Applications

Flow Cytometry

Clone

4C8

Description

Cambridge pathology 1 Ag; CAMPATH-1; Epididymal secretory protein E5; HE5

Host Species

Mouse

Purification Method

Affinity Purified

Regulatory Status

RUO

Target Species

Human

Isotype

IgG3 κ

Related Products

Img

BD Biosciences

BDB562945

--

Img

BD Biosciences

BDB563305

--

Img

BD Biosciences

BDB562254

--

Img

BD Biosciences

BDB563570

--

Img

BD Biosciences

BDB563571

--

Img

BD Biosciences

BDB562638

--

Img

BD Biosciences

BDB562249

--

Img

BD Biosciences

BDB562205

--

Description

  • The 4C8 monoclonal antibody specifically binds to CD52 which is also known as Cambridge pathology 1 antigen (CAMPATH-1) or Human epididymis-specific protein 5 (HE5)
  • CD52 is a highly N-glycosylated, 25-29 kDa protein whose C-terminus is glycophosphatidylinositol anchored in the membrane
  • It is highly expressed on the surface of thymocytes and mature lymphocytes but not on their stem cell precursors
  • It is also expressed on monocytes, dendritic cells, eosinophils and epithelial cells of the epididymis and seminal vesicles but not on neutrophils, plasma cells, platelets or erythrocytes
  • Although its functional role is not well characterized, the CD52 antigen serves as an exquisitely sensitive target antigen for antibody and complement-mediated lysis of CD52-positive cells
  • Anti-CD52 antibodies are being used clinically to remove lymphocytes from transplanted bone marrow cell preparations and in the treatment of some malignant diseases.